News

Webinar on Pulmonary Fibrosis in Scleroderma Patients to be Hosted by Scleroderma Research Foundation

The Scleroderma Research Foundation will host a free, live webinar on the relationship between pulmonary fibrosis (PF) and scleroderma on Thursday, November 13, at 10:00 a.m. PST. The Director of Biological Research for the Interstitial Lung Disease Program at University of California San Francisco (UCSF), Paul Wolters, will be the main lecturer…

Omnicare Subsidiaries Offers IPF Patient Support Services for Ofev

Two subsidiaries of Omnicare Specialty Care Group (SCG) recently announced they have been chosen to provide services to idiopathic pulmonary fibrosis (IPF) patients taking OFEV® (nintedanib), a recently-approved tyrosine kinase inhibitor developed by Boehringer Ingelheim. RxCrossroads and Advanced Care Scripts (ACS) have been selected to carry out reimbursement…

Researchers Present Relationship Between aPAP-related Pulmonary Fibrosis, ANCA-associated Systemic Vasculitis

In a study entitled “Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis” published in BMC Pulmonary Medicine the authors report the first evidence of a relationship between ANCA-associated systemic vasculitis and aPAP-related pulmonary fibrosis. Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare…

New Study To Measure Impact of Supplemental Oxygen in Pulmonary Fibrosis

A novel study on the impact of supplemental oxygen prescription in pulmonary fibrosis entitled “Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis” was published in the journal BMC Pulmonary Medicine by Amanda Belkin, part of Dr. Jeffrey J Swigris’group from Autoimmune Lung Center and Interstitial Lung…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums